fulvestrant,ipatasertib,Palbociclib
roche,Pfizer
['breast', ' fulv', 'ipatasertib']
in today's poster session on #breastcancer at #asco23, alicia okines &amp; nicholas turner's work is being presented on the phase ii study of fulvestrant &amp; cdk4/6 inhibition with ipatasertib in er+/her2- breast cancer patients. check out poster tps1111: 
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK